Stockreport

IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Imunon, Inc.  (IMNN) 
PDF LAWRENCEVILLE, N.J., Oct. 07, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN) (the “Company”), a clinical-stage company in late-stage development with its DNA-med [Read more]